Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction

2000 ◽  
Vol 75 (2-3) ◽  
pp. 253-260 ◽  
Author(s):  
Toshiyuki Takahashi ◽  
Toshihisa Anzai ◽  
Tsutomu Yoshikawa ◽  
Yasushi Asakura ◽  
Shiro Ishikawa ◽  
...  
2021 ◽  
pp. 1-4
Author(s):  
Sadeq Tabatabai ◽  
Nooshin Bazargani ◽  
Kamaleldin Al-Tahmody ◽  
Jasem Mohammed Alhashmi

Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging.


1996 ◽  
Vol 132 (5) ◽  
pp. 959-963 ◽  
Author(s):  
Masaharu Ishihara ◽  
Hikaru Sato ◽  
Hironobu Tateishi ◽  
Takuji Kawagoe ◽  
Yuji Shimatani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document